Well Referenced

Tag: Viscum album

High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series

This 2015 retrospective case series evaluated the potential of high-dose Viscum album (European mistletoe) extract therapy in preventing bladder cancer recurrence. Eight patients with resectable bladder cancer (7 non-muscle-invasive, 1 muscle-invasive) received subcutaneous injections of high-dose Viscum album extract between 2006 and 2012. Prior to this therapy, patients had experienced

Read More »
June 26, 2025 No Comments

Tumour Cell Derived Effects on monocyte/macrophage Polarization and Function and Modulatory Potential of Viscum Album Lipophilic Extract in Vitro

This in vitro study examined the effects of Viscum album (mistletoe) lipophilic extract on the polarization and function of monocytes/macrophages derived from tumor cells. The research found that mistletoe extract significantly modulated immune cell functions, potentially enhancing the immune system’s ability to target and destroy cancer cells. While the study’s

Read More »
June 26, 2025 No Comments

Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology

This study investigates the safety and adverse effects of intratumoral (IT) mistletoe injections in 123 cancer patients, examining the incidence and severity of adverse drug reactions (ADRs) from 862 injections using preparations like Abnoba Viscum and Helixor. The study found that 21.1% of patients experienced mild ADRs, including localized reactions

Read More »
June 26, 2025 No Comments

Use of Iscador, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment: Prospective Nonrandomized and Randomized Matched-Pair Studies Nested Within a Cohort Study

This study examines the effectiveness of Iscador, a mistletoe extract, in prolonging survival in cancer patients, with results showing a 40% longer survival in Iscador-treated patients compared to controls. The study involved 10,226 cancer patients, with 1,668 receiving Iscador. It found that Iscador treatment, when combined with psychosomatic self-regulation, significantly

Read More »
June 26, 2025 No Comments

Viscum album L. Therapy in Oncology: An Update on Current Evidence

This review article highlights the use of Viscum album (mistletoe) extracts in oncology, showing evidence that these extracts can improve health-related quality of life (HRQL) and potentially prolong survival in cancer patients. It emphasizes the anti-tumor, immunomodulatory, and pro-apoptotic effects of VA extracts, which are commonly used as adjunct therapies

Read More »
June 26, 2025 No Comments

White-Berry Mistletoe (Viscum album L.) as complementary treatment in cancer: Does it help?

White-berry mistletoe (Viscum album L.) has been explored as a complementary cancer therapy, with studies suggesting it may improve response rates, overall survival, and quality of life while reducing side effects from conventional cancer treatments. The extracts, rich in biologically active substances like mistletoe lectins and viscotoxins, have demonstrated immune-stimulating

Read More »
June 26, 2025 No Comments

ARE MISTLETOE EXTRACT INJECTIONS THE NEXT BIG THING IN CANCER THERAPY?

This article from Johns Hopkins Magazine highlights the personal story of Ivelisse Page, a colon cancer patient who, after surgery, declined chemotherapy and opted for mistletoe extract (Viscum album) injections under the supervision of her oncologist, Dr. Luis Diaz. Following treatment, she reported improved well-being and has remained cancer-free, which

Read More »
June 26, 2025 No Comments